SciHub
文献互助
期刊查询
一搜即达
科研导航
交流社区
即时热点
登录
注册
发布
文献
求助
首页
我的求助
捐赠本站
theseus
Lv2
2
110 积分
2024-06-20 加入
最近求助
最近应助
互助留言
932MO Nivolumab (NIVO) plus platinum-doublet chemotherapy (chemo) versus chemo as neoadjuvant treatment for resectable non-small cell lung cancer (NSCLC): Health-related quality of life (HRQoL) outcomes from CheckMate 816
2小时前
待确认
Perioperative immune checkpoint blockades improve prognosis of resectable non-small cell lung cancer
9小时前
已关闭
NSCLC, early stage Neoadjuvant anti-PD1, nivolumab, in early stage resectable non-small-cell lung cancer
10小时前
已完结
Survival and Early Death Within Three Months from the Start of Immune Checkpoint Inhibitors in Patients With Different Types of Cancer
16小时前
已完结
Probabilistic sensitivity analysis in health economics
2个月前
已完结
Lung Adjuvant Cisplatin Evaluation: A Pooled Analysis by the LACE Collaborative Group
2个月前
已完结
Non-Small Cell Lung Cancer: Epidemiology, Risk Factors, Treatment, and Survivorship
2个月前
已完结
A Step-by-Step Guide to Propensity Score Matching in R
3个月前
已完结
Perioperative Toripalimab Plus Chemotherapy for Patients With Resectable Non–Small Cell Lung Cancer
3个月前
已完结
Atezolizumab plus bevacizumab and chemotherapy in non-small-cell lung cancer (IMpower150): key subgroup analyses of patients with EGFR mutations or baseline liver metastases in a randomised, open-label phase 3 trial
3个月前
已完结
没有进行任何应助
已找到【积分已退回】
9小时前
感谢
3个月前
最近帖子
最近评论
没有发布任何帖子
没有发布任何评论